Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency
Synonyms	3β-HSD deficiency
Pronounce
Specialty	Endocrinology
Symptoms	Ambiguous genitalia, salt-wasting crisis, hypotension, hypoglycemia
Complications	N/A
Onset	Neonatal
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the HSD3B2 gene
Risks	Family history of the condition
Diagnosis	Blood test, genetic testing
Differential diagnosis	Other forms of congenital adrenal hyperplasia
Prevention	Genetic counseling
Treatment	Glucocorticoid and mineralocorticoid replacement therapy
Medication	Hydrocortisone, fludrocortisone
Prognosis	Variable, depending on severity and treatment
Frequency	Rare
Deaths	N/A

Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (CAH due to 3β-HSD deficiency) is a rare form of congenital adrenal hyperplasia (CAH), a group of inherited disorders affecting the adrenal glands. This condition is caused by mutations in the HSD3B2 gene, which encodes the enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD). This enzyme is crucial for the biosynthesis of steroid hormones, including cortisol, aldosterone, and sex steroids.

Pathophysiology

The deficiency of 3β-HSD disrupts the normal production of steroid hormones. This leads to a buildup of precursor hormones and a deficiency in the end products. The lack of cortisol can result in adrenal insufficiency, while the deficiency in aldosterone can cause salt-wasting. The imbalance in sex steroids can lead to ambiguous genitalia in affected individuals.

Clinical Presentation

The clinical manifestations of CAH due to 3β-HSD deficiency can vary widely. Common symptoms include:

• Ambiguous genitalia in newborns
• Salt-wasting crisis in infancy
• Adrenal insufficiency
• Hypotension
• Hyponatremia
• Hyperkalemia

Diagnosis

Diagnosis is typically made through a combination of clinical presentation, hormonal assays, and genetic testing. Elevated levels of 17-hydroxypregnenolone and dehydroepiandrosterone (DHEA) with low levels of cortisol and aldosterone are indicative of the disorder. Genetic testing can confirm mutations in the HSD3B2 gene.

Treatment

Management of CAH due to 3β-HSD deficiency involves hormone replacement therapy to correct the deficiencies in cortisol and aldosterone. This typically includes:

• Glucocorticoid replacement
• Mineralocorticoid replacement
• Salt supplementation

Prognosis

With appropriate treatment, individuals with CAH due to 3β-HSD deficiency can lead relatively normal lives. However, ongoing medical supervision is necessary to manage hormone levels and prevent complications.

Related Pages

• Congenital adrenal hyperplasia
• Adrenal insufficiency
• Steroid hormone
• HSD3B2

   This article is a medical stub. You can help WikiMD by expanding it!